Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial

MLA

L. Masae Kawamura, et al. “Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial.” Annals of Internal Medicine, vol. 137, Oct. 2002, p. 640. EBSCOhost, https://doi.org/10.7326/0003-4819-137-8-200210150-00007.

APA

L. Masae Kawamura, John Bernardo, Eric Vittinghoff, Jussi J. Saukkonen, Robert M. Jasmer, Henry M. Blumberg, Mark D. King, Charles L. Daley, & Philip C. Hopewell. (2002). Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial. Annals of Internal Medicine, 137, 640. https://doi.org/10.7326/0003-4819-137-8-200210150-00007

Chicago

L. Masae Kawamura, John Bernardo, Eric Vittinghoff, Jussi J. Saukkonen, Robert M. Jasmer, Henry M. Blumberg, Mark D. King, Charles L. Daley, and Philip C. Hopewell. 2002. “Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial.” Annals of Internal Medicine 137 (October): 640. doi:10.7326/0003-4819-137-8-200210150-00007.